MAK CAPITAL ONE LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MAK CAPITAL ONE LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$40,056,000
+60.6%
6,642,814
-4.1%
13.12%
+31.6%
Q3 2019$24,947,000
+34.3%
6,929,6530.0%9.97%
+13.2%
Q2 2019$18,571,000
-9.5%
6,929,6530.0%8.81%
-20.3%
Q1 2019$20,512,000
+148.5%
6,929,653
+33.5%
11.06%
+147.3%
Q4 2018$8,255,000
+15.3%
5,191,600
+166.8%
4.47%
+90.8%
Q3 2018$7,162,0001,946,1072.34%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders